NRAS and melanoma: Treatment with 10 μM 2-BP for 2 h in WM3000 melanoma cells caused a reduction in the expression level of palmitoylated NRAS, while 20 μM 2-BP treatment for 3 min in HeLa S2 cells expressing EGFP-NRAS caused it to delocalize from the plasma membrane [188].